Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Cogstate Limited

Market Cap 476M 337M 291M 267M 251M 471M 31.86B 3.16B 1.23B 15.6B 1.27B 1.24B 53.98B P/E Ratio 2026 *
28.3x
P/E Ratio 2027 * 22.8x
Enterprise Value 417M 296M 255M 235M 220M 413M 27.94B 2.77B 1.08B 13.68B 1.11B 1.09B 47.35B EV / Sales 2026 *
4.97x
EV / Sales 2027 * 4.21x
Free-Float
54.16%
Yield 2026 *
1.1%
Yield 2027 * 1.47%

Last Transcript: Cogstate Limited

1 day+5.00%
1 week+10.92%
Current month+3.85%
1 month+11.70%
3 months+21.94%
6 months+20.77%
Current year+18.12%
1 week 1.8
Extreme 1.8
1.89
1 month 1.7
Extreme 1.7001
1.89
Current year 1.26
Extreme 1.26
1.89
1 year 0.96
Extreme 0.9575
2.1
3 years 0.55
Extreme 0.553
2.1
5 years 0.55
Extreme 0.553
2.1
10 years 0.14
Extreme 0.14
2.1
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Change 5-day change 1-year change 3-year change Capi.($)
+5.00%+10.92% - - 328M
+0.96%+1.16%-12.70%-12.33% 43.03B
+3.80%+7.50%+301.38%+534.96% 32.71B
-2.58%-3.66%+11.13%-18.36% 30.29B
+1.03%-1.81%+0.56%+32.27% 29.4B
+1.16%+2.10%+14.27%+22.05% 25.08B
+2.45%+8.47% - - 13.54B
-0.12%+1.69%+54.70%+111.06% 13.35B
-1.09%-2.31%+3.49%+5.00% 12.97B
+0.52%+0.12%+108.94%+76.61% 12.11B
Average +1.04%+0.83%+60.22%+93.91% 23.61B
Weighted average by Cap. +0.73%+0.82%+60.92%+102.50%

Financials

2026 *2027 *
Net sales 84.07M 59.55M 51.32M 47.24M 44.31M 83.24M 5.63B 558M 218M 2.76B 223M 219M 9.54B 96.14M 68.1M 58.7M 54.02M 50.68M 95.19M 6.44B 639M 249M 3.15B 256M 250M 10.91B
Net income 16.57M 11.73M 10.11M 9.31M 8.73M 16.4M 1.11B 110M 42.98M 543M 44.03M 43.1M 1.88B 20.73M 14.68M 12.65M 11.65M 10.93M 20.52M 1.39B 138M 53.78M 680M 55.1M 53.93M 2.35B
Net Debt -58.46M -41.41M -35.69M -32.85M -30.82M -57.89M -3.91B -388M -152M -1.92B -155M -152M -6.63B -70.91M -50.23M -43.29M -39.84M -37.38M -70.21M -4.75B -471M -184M -2.32B -188M -184M -8.04B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
12/06/26 1.890 $ +5.00% 5,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.800AUD
Average target price
3.175AUD
Spread / Average Target
+13.39%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!